{
  "paper_metadata": {
    "pmid": "39554377",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses a BRCA2 pathogenic variant found in a cohort of Somali women with ovarian cancer, along with penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1707_1708delGA",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Age 65, Female, Somali ethnicity",
        "phenotype": "Ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_4",
          "age_at_evaluation": 65,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "High-Grade Serous Ovarian Cancer",
          "evidence_sentence": "One patient carried a BRCA2 germline pathogenic variant."
        }
      ],
      "functional_data": {
        "summary": "The specific functional impact of this variant is not detailed in the paper.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "unknown",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The paper does not provide detailed functional data or population frequency for the BRCA2 variant.",
      "key_quotes": [
        "One patient carried a BRCA2 germline pathogenic variant."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper provided clear information regarding the BRCA2 variant."
  }
}